Global Molecular Infectious Disease Testing Market OverviewThe global Molecular Infectious Disease Testing Market encompasses ...

The molecular diagnostics sector continues to evolve as companies shift focus from pandemic-driven demand toward broader ...

Molecular Diagnostics Market is experiencing steady expansion, driven by the global shift toward rapid, decentralized, and ...

Shares in Abingdon Health PLC (AIM:ABDX) rose 14% to 8.24p after the AIM-listed rapid diagnostic test developer announced contracts worth approximately £4.8 million to develop and scale up the ...

Advancing Global Commercialization Strategy Through CoSara and CoMira Joint Ventures Progressing Clinical Pipeline and Regulatory Pathways for PCR Platform Strengthening ...

On India, Egan described CoSara as having “a nationwide commercial presence,” “hundreds of laboratory customers,” and “15 PCR tests cleared through India's regulatory pathway,” and said “CoSara has ...

The cobas MPX-E test provides four critical results (for HIV, HCV, HBV, and HEV) in a single test, increasing laboratory ...

In this edition of the biotech bi-weekly, get the latest biotech updates, including the collaboration facilitating the launch ...

Welcome to Trade Secrets, TheWrap's insider guide to making it in Hollywood. For this installment, we tackle perhaps the ...

The assay is developed to address current demands of laboratories.

The York-headquartered company said the agreements span around 27 months and will cover the full lifecycle of product development - from feasibility and regulatory planning through to large-scale manu ...

The final trading session of Q1 2026 highlights the diverse strategies within the pharmaceutical industry, marked by significant product introductions and clinical progress. From Roche's new ...